Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Citron

Showing results (331-340 of 590) with videos related to

Pageof 59
Sort By:
Antimicrobial Agents and Chemotherapy|June 27, 2012
MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficileMichelle M Butler, Dean L Shinabarger, Diane M Citron, et al.
Annals of Emergency Medicine|March 1, 2017
Clostridium difficile Infection Among US Emergency Department Patients With Diarrhea and No VomitingFredrick M Abrahamian, David A Talan, Anusha Krishnadasan, et al.
Anaerobe|May 17, 2006
Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolatesM C Claros, Z C Claros, D W Hecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1997
Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase CJ Walter, J Grünberg, A Capell, et al.
The Journal of Biological Chemistry|June 23, 1998
Amyloid precursor protein processing in sterol regulatory element-binding protein site 2 protease-deficient Chinese hamster ovary cellsS L Ross, F Martin, L Simonet, et al.
Anaerobe|June 11, 2018
Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015Adam Cheknis, Stuart Johnson, Laurent Chesnel, et al.
Neurobiology of Disease|September 25, 1998
Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-proteinM Citron, C B Eckman, T S Diehl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2020
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor OutcomesStuart Johnson, Diane M Citron, Dale N Gerding, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
Multilaboratory comparison of anaerobe susceptibility results using 3 different agar mediaD E Roe, S M Finegold, D M Citron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
Multilaboratory comparison of growth characteristics for anaerobes, using 5 different agar mediaD E Roe, S M Finegold, D M Citron, et al.
Pageof 59

Showing results (331-340 of 590) with videos related to

Sort By:
Pageof 59
Antimicrobial Agents and Chemotherapy|June 27, 2012
MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficileMichelle M Butler, Dean L Shinabarger, Diane M Citron, et al.
Annals of Emergency Medicine|March 1, 2017
Clostridium difficile Infection Among US Emergency Department Patients With Diarrhea and No VomitingFredrick M Abrahamian, David A Talan, Anusha Krishnadasan, et al.
Anaerobe|May 17, 2006
Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolatesM C Claros, Z C Claros, D W Hecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1997
Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase CJ Walter, J Grünberg, A Capell, et al.
The Journal of Biological Chemistry|June 23, 1998
Amyloid precursor protein processing in sterol regulatory element-binding protein site 2 protease-deficient Chinese hamster ovary cellsS L Ross, F Martin, L Simonet, et al.
Anaerobe|June 11, 2018
Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015Adam Cheknis, Stuart Johnson, Laurent Chesnel, et al.
Neurobiology of Disease|September 25, 1998
Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-proteinM Citron, C B Eckman, T S Diehl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2020
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor OutcomesStuart Johnson, Diane M Citron, Dale N Gerding, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
Multilaboratory comparison of anaerobe susceptibility results using 3 different agar mediaD E Roe, S M Finegold, D M Citron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
Multilaboratory comparison of growth characteristics for anaerobes, using 5 different agar mediaD E Roe, S M Finegold, D M Citron, et al.
Pageof 59